Greenfern Industries Limited Ordinary Shares Company Details Registered Office: 127 Normanby Road, Normanby 4671 Postal Address: 127 Normanby Road, Normanby 4671 Telephone: +64-27-420-2476 Facsimile
By Suze Metherell Aug. 27 (BusinessDesk) - New Zealand shares rose to a record as Pacific Edge won a contract with US healthcare provider Kaiser Permanente and Genesis Energy posted earnings that b
Pacific Edge is still working through the implications of the Medicare contractor decision that its suite of products do not meet the threshold for coverage under the US Social Security Act. Trading
Cancer diagnostics company Pacific Edge has come out swinging against a decision by Novitas, the Medicare administrative contractor with jurisdiction for its US laboratory, that would end reimbursemen
The long-awaited draft Local Coverage Determination from Novitas is not good news for Pacific Edge’s US business. According to the determination (LCD), “CxBladder tests are not reasonable and ne
Pacific Edge’s shares jumped as much as 6.3% as investors wait for the cancer diagnostic company to reveal whether major US health insurance provider will keep using its bladder tests. The S&P/NZX 5
By Paul McBeth Nov. 20 (BusinessDesk) - Bethunes Investments shareholders will vote next month on a deal to use its NZX listing as a vehicle for freight and logistics firm Transport Investments Ltd to
Cancer diagnostics business Pacific Edge will apply for a secondary listing on the Australian stock exchange and expects its shares to begin trading on ASX in September. The firm’s board said being
News that Pacific Edge won’t lose Medicare Insurance until April is good news but no guarantee of a reprieve, analysts say. “Although this delay is positive, we think a fair base case is that [
Pacific Edge has long wanted to crack the United States market, which it has seen for a long time as validating the hundreds of millions spent in developing its Cxbladder non-invasive cancer detection
Shares in cancer diagnostics company Pacific Edge soared on news that the American Urological Association has included Cxbladder Triage in its clinical guideline for caring for patients with microscop
Cancer diagnostics company Pacific Edge soared more than 100% after improving its standing in the United States, and the New Zealand sharemarket gained nearly 0.5% on a busy day. The S&P/NZX 50 Index.
Marlin Global Limited 20/05/2022 $1.28 Warrants
New Zealand Rugby is poised for its biggest structural change in 25 years of professionalism with the bulk of its income and expenses carved out into a subsidiary if the controversial Silver Lake deal
A judgment is expected to be delivered on Thursday. The S&P/NZX 50 index declined 122.94 points or 1.03% to 11,759.15....
Forsyth Barr and Jarden analysts have raised their target prices for exchange operator NZX following a 10% guidance lift. NZX Ltd said Monday it expects full-year 2024 operating earnings before inte
A judgment is expected to be delivered on Thursday. The S&P/NZX 50 index declined 122.94 points or 1.03% to 11,759.15....
By Paul McBeth Oct. 27 (BusinessDesk) - New Plymouth-based freight and logistics group Transport Investments Ltd plans to join the NZX through a backdoor listing via Bethunes Investment in a deal valu
The Asia Pacific Trust ("the Fund") is a unit trust, as defined in the Units Trust Act 1960.The beneficial interest in the Fund is divided into units, with each unit representing an equal interest in.
Pacific Edge Limited is a cancer diagnostic company specialising in the discovery and commercialisation of diagnostic and prognostic tests for the better detection and management of cancer. The compan
Manawa Energy Limited Ordinary Shares Company Details Registered Office: 108 Durham Street, Tauranga 3110 Postal Address: 108 Durham Street, Tauranga 3110 Telephone: +64-27-582-6600 Facsimile: n/a Web
2 Cheap Cars Group Limited Ordinary Shares Company Details Registered Office: 102 Mays Road, Onehunga, Auckland 1061 Postal Address: 102 Mays Road, Onehunga, Auckland 1061 Telephone: 09-869-3330 Facsi
Dunedin-headquartered cancer diagnostics company Pacific Edge has posted a $14.5 million after-tax loss for the six months to September 30. The NZX and ASX-listed company said it was awaiting outcomes
Third party data: All data displayed on the FundSource pages (Data) on BusinessDesk has been sourced from an independent third party, FE Fundinfo. NZME and its related bodies corporate and affiliates (together NZME) do not make any representation as to the currency, fairness, accuracy, completeness or reliability of the Data. Nor will NZME have any liability to any person in relation to the use of or reliance on the Data.
No financial or investment advice: The Data is general information only. It is not financial product or investment advice or an investment recommendation, and has not been prepared taking into account the objectives, financial situation or needs of any person. Potential investors should seek their own independent advice from a qualified financial adviser prior to making an investment decision. NZME makes no recommendation in relation to, and accept no responsibility or ongoing liability for, any person’s investment decisions.
No offer: The Data is only to be accessed by New Zealand residents from within New Zealand, and may not be copied or distributed to any other person. The Data does not constitute an offer or solicitation to offer financial products or conduct investment business in New Zealand or any other jurisdiction.
No guarantee: Past performance information should not be relied upon as (and is not) a promise, representation, warranty or guarantee as to the past, present or future performance. NZME does not guarantee repayment of any capital or payment of any returns on capital invested in the investments referred to in the Data.
Missing data? All data comes from FE fundinfo. BusinessDesk can help you get your data loaded and updated. Email [email protected] for help.